日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trial

帕博利珠单抗联合伏立诺他治疗复发和/或转移性鳞状细胞癌患者的疗效:一项 II 期篮式试验

Borcoman, Edith; Cabarrou, Bastien; Francisco, Miguel; Bigot, Frédéric; Ghiringhelli, François; Vansteene, Damien; Legrand, François; Halladjian, Maral; Dupain, Célia; Le Saux, Olivia; Coutzac, Clelia; Borel, Christian; Chaltiel, Raphael; You, Benoit; Gomez-Roca, Carlos; Cousin, Sophie; Coquan, Elodie; Lambert, Aurélien; Saada-Bouzid, Esma; Durando, Xavier; Saint-Ghislain, Mathilde; Frige, Gianmaria; Guerini-Rocco, Elena; Tonini, Maria Manuela; Bièche, Ivan; Castel-Ajgal, Zahra; Marret, Grégoire; Sablin, Marie-Paule; Jeannot, Emmanuelle; Andre, Fabrice; Filleron, Thomas; Jimenez, Marta; Mazzarella, Luca; Servant, Nicolas; Kamal, Maud; Le Tourneau, Christophe

Lower probability and shorter duration of infections after COVID-19 vaccine correlate with anti-SARS-CoV-2 circulating IgGs

新冠疫苗接种后感染概率降低和感染持续时间缩短与体内抗SARS-CoV-2 IgG抗体循环水平相关。

Ronchini, Chiara; Gandini, Sara; Pasqualato, Sebastiano; Mazzarella, Luca; Facciotti, Federica; Mapelli, Marina; Frige', Gianmaria; Passerini, Rita; Pase, Luca; Capizzi, Silvio; Mastrilli, Fabrizio; Orecchia, Roberto; Natoli, Gioacchino; Pelicci, Pier Giuseppe

Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer.

获得性 CYP19A1 扩增是 ERα 转移性乳腺癌中芳香化酶抑制剂耐药性的早期特异性机制

Magnani Luca, Frige Gianmaria, Gadaleta Raffaella Maria, Corleone Giacomo, Fabris Sonia, Kempe Mannus H, Verschure Pernette J, Barozzi Iros, Vircillo Valentina, Hong Sung-Pil, Perone Ylenia, Saini Massimo, Trumpp Andreas, Viale Giuseppe, Neri Antonino, Ali Simak, Colleoni Marco Angelo, Pruneri Giancarlo, Minucci Saverio